Electromed, Inc. (ELMD)

NYSEAMERICAN: ELMD · IEX Real-Time Price · USD
11.05
-0.24 (-2.13%)
Feb 7, 2023, 4:00 PM EST - Market closed
-2.13%
Market Cap 93.76M
Revenue (ttm) 42.32M
Net Income (ttm) 1.95M
Shares Out 8.49M
EPS (ttm) 0.22
PE Ratio 50.23
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 11,277
Open 11.10
Previous Close 11.29
Day's Range 11.05 - 11.38
52-Week Range 8.75 - 13.25
Beta 0.51
Analysts Buy
Price Target 17.09 (+54.66%)
Earnings Date Feb 14, 2023

About ELMD

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology... [Read more]

Industry Medical Devices
Sector Healthcare
IPO Date Aug 13, 2010
Employees 156
Stock Exchange NYSEAMERICAN
Ticker Symbol ELMD
Full Company Profile

Financial Performance

In 2022, Electromed's revenue was $41.66 million, an increase of 16.51% compared to the previous year's $35.76 million. Earnings were $2.31 million, a decrease of -2.41%.

Financial Statements

Analyst Forecast

According to 8 analysts, the average rating for ELMD stock is "Buy." The 12-month stock price forecast is $17.09, which is an increase of 54.66% from the latest price.

Price Target
$17.09
(54.66% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Electromed, Inc. Schedules its Second Quarter Fiscal 2023 Financial Results Conference Call for February 14, 2023 at 5:00 p.m. ET

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue i...

1 week ago - Business Wire

Electromed, Inc. Announces U.S. Food and Drug Administration 510(k) Clearance of Fifth Generation HFCWO Airway Clearance Generator

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (NYSE American: ELMD) a leader in innovative airway clearance technologies, today announced that it received U.S Food and Drug Administration (“F...

2 months ago - Business Wire

Electromed, Inc. Announces Fiscal 2023 First Quarter Results

NEW PRAGUE, Minn.

3 months ago - Business Wire

Electromed, Inc. to Participate in Two Upcoming Investor Conferences

NEW PRAGUE, Minn.

3 months ago - Business Wire

Electromed, Inc. Appoints Brad Nagel as Chief Financial Officer

NEW PRAGUE, Minn.

3 months ago - Business Wire

Electromed, Inc. to Participate in the Issuer Direct 2022 Windy City Roundup

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. to Participate in the Issuer Direct 2022 Windy City Roundup

4 months ago - Business Wire

Electromed, Inc. Announces Fiscal 2022 Fourth Quarter and Full Year Financial Results

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. Announces Fiscal 2022 Fourth Quarter and Full Year Financial Results

6 months ago - Business Wire

Electromed, Inc. Schedules its Fourth Quarter and Fiscal 2022 Financial Results Conference Call for August 23, 2022 at 5:00 p.m. ET

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. Schedules its Fourth Quarter and Fiscal 2022 Financial Results Conference Call for August 23, 2022 at 5:00 p.m. ET

6 months ago - Business Wire

Electromed, Inc. Announces Election of Andrew Summers as Additional Independent Director

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (“Electromed”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it has elected a new independent d...

7 months ago - Business Wire

Electromed, Inc. to Participate in the Canaccord Genuity 42nd Annual Growth Conference

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. to Participate in the Canaccord Genuity 42nd Annual Growth Conference

7 months ago - Business Wire

7 Lesser-Known Small-Cap Stocks to Keep on Your Watchlist

These small-cap stocks just might fly underneath the drama yet still pack enormous potential to rise up over the long haul. The post 7 Lesser-Known Small-Cap Stocks to Keep on Your Watchlist appeared ...

Other symbols: AFCGAMOTDHCPRTSSBHUP
8 months ago - InvestorPlace

Electromed, Inc. Announces Clinical Abstract Poster at ATS Conference: Bronchiectasis Patients Showed Improved Outcomes and Reduction in Healthcare Resource Utilization When Using HFCWO Therapy

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (NYSE American: ELMD) today announced the results of a third-party, clinical study presented as a clinical abstract poster at the American Thoracic...

9 months ago - Business Wire

Electromed, Inc. Announces Third Quarter Financial Results

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. Announces Third Quarter Financial Results

9 months ago - Business Wire

Electromed, Inc. to Participate in the Sidoti & Co. May Micro Cap Virtual Investor Conference

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. to Participate in the Sidoti & Co. May Micro Cap Virtual Investor Conference

10 months ago - Business Wire

Electromed, Inc. Schedules its Third Quarter Fiscal 2022 Financial Results Conference Call for May 10, 2022 at 5:00 p.m. ET

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. Schedules its Third Quarter Fiscal 2022 Financial Results Conference Call for May 10, 2022 at 5:00 p.m. ET

10 months ago - Business Wire

Electromed, Inc., Appoints Christopher Holland Chief Commercial Officer

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc., Appoints Christopher Holland Chief Commercial Officer

1 year ago - Business Wire

Electromed, Inc. Announces Second Quarter Financial Results

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. Announces Second Quarter Financial Results

1 year ago - Business Wire

Electromed, Inc. Schedules its Second Quarter Fiscal 2022 Financial Results Conference Call for February 8, 2022 at 5:00 p.m. ET

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its...

1 year ago - Business Wire

Electromed, Inc. (ELMD) Upgraded to Buy: Here's What You Should Know

Electromed, Inc. (ELMD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

1 year ago - Zacks Investment Research

Electromed, Inc. to Participate in the Sidoti December Virtual Micro Cap Investor Conference

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Kathleen Skarvan,...

1 year ago - Business Wire

Bears are Losing Control Over Electromed, Inc. (ELMD), Here's Why It's a 'Buy' Now

Electromed, Inc. (ELMD) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement amo...

1 year ago - Zacks Investment Research

Electromed, Inc. (ELMD) Lags Q1 Earnings Estimates

Electromed, Inc. (ELMD) delivered earnings and revenue surprises of -16.67% and 11.12%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

1 year ago - Zacks Investment Research

Electromed, Inc. Announces Fiscal 2022 First Quarter Financial Results

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for ...

1 year ago - Business Wire

Electromed, Inc. (ELMD) Reports Next Week: What Awaits?

Electromed, Inc. (ELMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 year ago - Zacks Investment Research